Q3 2026 13F · SEC CIK 1944780
Acute Investment Advisory, LLC
Wealth managerFiled 2026-10-16 for Q3 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $9.0M
- Reported positions
- 17
- Top holdings a year, 3 yrs
- +2.8%
- Assets under management
- $238.4M
Acute Investment Advisory, LLC is a wealth manager that reported 17 positions worth $9.0M in its Q3 2026 13F, filed 2026-10-16. Its largest holdings were Emerson Elec Co (EMR, 20.7%), Spdr Series Trust (SPHY, 8.5%), Invesco Exch Traded Fd Tr II (PGX, 8.4%). A portfolio copying its top holdings returned 2.8% a year over the last 3 years, against 22.3% for the S&P 500.
Acute Investment Advisory, LLC holdings all 17 positions.
Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| EMREmerson Elec Co | 20.7% | +0.0% | $1.9M |
| SPHYSpdr Series Trust | 8.5% | -2.4% | $767K |
| PGXInvesco Exch Traded Fd Tr II | 8.4% | -2.6% | $759K |
| VTWOVanguard Scottsdale Fds | 6.9% | -5.1% | $617K |
| AAPLApple Inc | 5.7% | +1.3% | $517K |
| QQQMInvesco Exch Traded Fd Tr II | 5.7% | -1.4% | $514K |
| IVVIshares Tr | 5.2% | -3.3% | $469K |
| SPMBSpdr Ser Tr | 5.2% | -2.5% | $467K |
| IWMIshares Tr | 5.1% | -4.6% | $460K |
| VGLTVanguard Scottsdale Fds | 5.1% | -8.7% | $456K |
| SPYState Str Spdr S&p 500 ETF T | 4.8% | -4.7% | $431K |
| QQQInvesco Qqq Tr | 3.5% | -3.0% | $316K |
| MGKVanguard World Fd | 3.5% | -3.1% | $313K |
| COSTCostco Wholesale Corporation | 3.5% | +0.0% | $311K |
| HYGHIshares U S ETF Tr | 2.9% | -2.5% | $261K |
| SPYVState Street Spdr Portfolio S&p 500 Valu | 2.7% | -2.5% | $240K |
| DGROIshares Tr | 2.6% | -3.4% | $231K |
What Acute Investment Advisory, LLC bought and sold in Q3 2026, against Q2 2026.
New positions
No new positions among the largest holdings.
Added to
No position grew by more than 5%.
Reduced
- VGLT Vanguard Scottsdale Fds-8.7% shares
- VTWO Vanguard Scottsdale Fds-5.1% shares
Sold out
- LRCX Lam Research Corpwas 2.3%
Share counts compared with the Q2 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +6.7% /yr
- S&P 500 +11.7%
- 3 years
- +2.8% /yr
- S&P 500 +22.3%
- 5 years
- +1.3% /yr
- S&P 500 +16.9%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q3 2026 | $9.0M | 17 |
| Q2 2026 | $9.5M | 18 |
| Q1 2026 | $8.9M | 18 |
| Q4 2025 | $10.3M | 15 |
| Q3 2025 | $11.9M | 17 |
| Q2 2025 | $12.3M | 17 |
| Q1 2025 | $19.9M | 17 |
| Q4 2024 | $91.1M | 17 |
| Q3 2024 | $174.1M | 15 |
| Q2 2024 | $175.4M | 14 |
| Q1 2024 | $149.1M | 10 |
| Q4 2023 | $169.1M | 13 |
Questions about Acute Investment Advisory, LLC's portfolio
What stocks does Acute Investment Advisory, LLC own?
Acute Investment Advisory, LLC's latest 13F, for Q3 2026 and filed Oct 16, 2026, lists 17 positions worth $9.0M. The largest are Emerson Elec Co (EMR) at 20.7%, Spdr Series Trust (SPHY) at 8.5%, Invesco Exch Traded Fd Tr II (PGX) at 8.4%, Vanguard Scottsdale Fds (VTWO) at 6.9% and Apple Inc (AAPL) at 5.7%.
What did Acute Investment Advisory, LLC buy last quarter?
Acute Investment Advisory, LLC opened no new positions and grew none by more than 5% among its largest holdings in Q3 2026.
What did Acute Investment Advisory, LLC sell last quarter?
In Q3 2026, Acute Investment Advisory, LLC sold all of Lam Research Corp (LRCX), Vanguard Scottsdale Fds (VGLT) (-8.7% shares) and Vanguard Scottsdale Fds (VTWO) (-5.1% shares), compared with its Q2 2026 filing.
How has Acute Investment Advisory, LLC's portfolio performed?
A portfolio copying Acute Investment Advisory, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +2.8% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +6.7% against +11.7%. Over 5 years: +1.3% a year against +16.9%.
When is Acute Investment Advisory, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Acute Investment Advisory, LLC's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.
How much money does Acute Investment Advisory, LLC manage?
Acute Investment Advisory, LLC reported $238.4M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $9.0M.